Expertise in
10
conditions

Pal A. Holme

Oslo, NO 
Expertise in
10
conditions
Oslo, NO 

Overview

Pal Holme practices practicing medicine in Oslo, Norway.

Mr. Holme is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Blood Clots, Hemophilia A, Hemophilia B, and Factor 7 Deficiency.

He is actively involved in clinical research, co-authoring 96 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Oslo, Norway
Other Locations
Tromso, Norway
Nydalen, 0424, Norway
Blindern, 0318, Norway

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Multicenter, Open-label Study of the Efficacy and Safety of B-Domain Deleted Recombinant Porcine Factor VIII (BAX 802) in Subjects With Congenital Hemophilia A With Factor VIII Inhibitors Undergoing Surgical or Other Invasive Procedures
A Phase 3, Multicenter, Open-label Study of the Efficacy and Safety of B-Domain Deleted Recombinant Porcine Factor VIII (BAX 802) in Subjects With Congenital Hemophilia A With Factor VIII Inhibitors Undergoing Surgical or Other Invasive Procedures
Enrollment Status: Terminated
Publish Date: October 20, 2021
Intervention Type: Biological
Study Phase: Phase 3
International Post-Marketing Surveillance of Willfact-Wilfactin in Patients With Inherited Von Willebrand Disease.
International Post-Marketing Surveillance of Willfact-Wilfactin in Patients With Inherited Von Willebrand Disease.
Enrollment Status: Completed
Publish Date: August 08, 2018
View 1 Less Clinical Trial

96 Total Publications

Interleukin-17-associated inflammation in non-responders and B-cell remodeling after daratumumab in refractory immune thrombocytopenia.
Interleukin-17-associated inflammation in non-responders and B-cell remodeling after daratumumab in refractory immune thrombocytopenia.
Journal: Haematologica
Published: April 09, 2026

Frequently Asked Questions about Pal A. Holme

Is Pal A. Holme a top-rated expert for Blood Clots?

MediFind is an objective health platform that identifies experts based on real-world data. Pal A. Holme is classified as an Distinguished expert for Blood Clots, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pal A. Holme participate in research or clinical trials?

Yes. Pal A. Holme has published 96 articles and abstracts on conditions like Blood Clots. You can view a list of Pal A. Holme's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Holme's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile